Even though its role is crucial, bioinformatics if only a small part of the overall $305 billion biotech sector, accounting for only about $2. 23 billion But some investors believe that bioinformatics has great potential SOUND BITE T So unless drug companies start developing their own bioinformatics systems or them, they may get left behind in the race to d iscover new drugEven though its role is crucial, bioinformatics if only a small part of the overall $305 billion biotech sector, accounting for only about $2.23 billion. But some investors believe that bioinformatics has great potential. ［SOUND BITE］ So unless drug companies start developing their own bioinformatics systems or partner with companies that can provide them, they may get left behind in the race to discover new drugs